Ketorolac Tromethamine Tablet
Brand names: Ketorolac Tromethamine
Category: Analgesia/Addiction
FDA status: To Be Discontinued · Last FDA update: Apr 20, 2026 · First posted: Apr 20, 2026 · 1 manufacturers, 1 listed presentations
As of Apr 20, 2026, the FDA lists Ketorolac Tromethamine Tablet as being discontinued. Of 1 manufacturer presentations, 1 Not specified.
| Presentation & package NDC | Manufacturer | Availability | FDA note |
|---|---|---|---|
| Ketorolac Tromethamine, Tablet, 10 mg (NDC 0378-1134-01) NDC 0378-1134-01 |
Mylan Pharmaceuticals Inc., a Viatris Company | Not specified | Discontinuation of the manufacture of the drug |
Related medications in shortage
Other Analgesia/Addiction medications currently on the FDA shortage list — useful context if you and your prescriber are weighing alternatives. Always confirm with your pharmacist.
Change log
Tracking began Oct 1, 2026. We check the FDA every 6 hours; any real change - a manufacturer moving from Limited to Available, a new recovery date, a new listing - shows up here with its date.
Cite this: “FDA drug-shortage status for Ketorolac Tromethamine Tablet (FDA data as of Apr 20, 2026). Shortage Watch, openFDA.”
Get an email when this record changes
One email, only when the FDA changes something for Ketorolac Tromethamine Tablet. You confirm by clicking a link first (double opt-in). No newsletter, no other mail.
Feeds instead of email: RSS or JSON. Unsubscribe anytime; see Privacy.
Embed a live status badge: /badge/ketorolac-tromethamine-tablet.svg
FDA data last synced Oct 1, 2026 (FDA record dated Sep 30, 2026).